ArticleClinicoEconomics and outcomes research : CEOR2024

Characteristics of High-Cost Beneficiaries of Prescription Drugs in Kazakhstan: A Cross-Sectional Study of Outpatient Data from 2022.

Adilet Nazarbayev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.